Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients

被引：0
|
作者：
Terrault, NA
Wright, TL
Roberts, JP
Ascher, NL
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] VAMC, San Francisco, CA USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
905
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [41] Reduced Hepatitis B Immunoglobulin (HBIg) Role in the Era of Potent Nucleos(t)ide Analogues for Hepatitis B Virus (HBV) Prophylaxis
    Singer, George
    Zielsdorf, Shannon
    Fleetwood, Vidyaratna
    Eswaran, Sheila
    Cohen, Eric
    Alvey, Nicole
    Chan, Edie
    Shah, Nikunj
    Fayek, Sameh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 100 - 100
  • [42] Lamivudine without HBIg for prevention of graft infection by hepatitis B; Long-term follow-up.
    Mutimer, DJ
    Grellier, L
    Barrett, CA
    Ahmed, M
    Burroughs, AK
    Anschuetz, GC
    Dusheiko, GM
    Elias, EA
    HEPATOLOGY, 1999, 30 (04) : 301A - 301A
  • [43] Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up
    Mutimer, D
    Dusheiko, G
    Barrett, C
    Grellier, L
    Ahmed, M
    Anschuetz, G
    Burroughs, A
    Hubscher, S
    Dhillon, AP
    Rolles, K
    Elias, E
    TRANSPLANTATION, 2000, 70 (05) : 809 - 815
  • [44] Risk factors for de novo hepatitis B virus reactivation in liver transplant recipient with long term HBIG treatment
    Umeda, Makoto
    Marusawa, Hiroyuki
    Ueda, Mikiko
    Tanaka, Yuichi
    Takada, Yasutsugu
    Egawa, Hiroto
    Uemoto, Shinji
    Chiba, Tsutomu
    GASTROENTEROLOGY, 2006, 130 (04) : A787 - A787
  • [45] Low Risk of Hepatitis B Virus (HBV) Recurrence after Withdrawal of Hepatitis B Immunoglobulin (HBIG) in a Liver Transplant(LT) Population on Oral Antivirals
    Agrawal, Nidhi
    Shechtel, Joanna L.
    Parpia, Tarina
    Fishbein, Thomas
    Shetty, Kirti
    HEPATOLOGY, 2012, 56 : 530A - 530A
  • [46] EARLY INTRODUCTION OF SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIg) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
    Samuel, D.
    De Simone, P.
    Salizoni, M.
    Pinna, A. D.
    Cillo, U.
    Zamboni, F.
    Mutimer, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S273 - S273
  • [47] Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: Long-term results
    Dumortier, J
    Chevallier, P
    Scoazec, JY
    Berger, F
    Boillot, O
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 999 - 1002
  • [48] Long-Term Outcomes of Prophylaxis with Entecavir and Hepatitis B Immunoglobulin After Liver Transplantation for Hepatitis B Virus
    Togashi, Junichi
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Arita, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    TRANSPLANTATION, 2016, 100 : S181 - S181
  • [49] Living Related Liver Transplant (LRLT) in HBV Related Liver Disease without Hepatitis B Immunoglobulin (HBIG).
    Wadhawan, Manav
    Gupta, Subash
    Goyal, Neerav
    Taneja, Sunil
    LIVER TRANSPLANTATION, 2013, 19 : S91 - S92
  • [50] Long-term outcomes of preventing HBV recurrence with nucleotide and HBIG after liver transplantation for hepatitis B associated liver disease
    Chang, S. H.
    TRANSPLANTATION, 2021, 105 (08) : 93 - 93
12345